ASSOCIATION FOR ACCESSIBLE MEDICINES

Lobbying client · District of Columbia · filed 2025 to 2026

National trade organization representing the interests of generic drug manufacturers.

$270,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (194417), not by name.

Firms hired 1

THE GIBSON GROUP, LLC $270,000 6 filings

Bills named in these filings 3

S 1040
Drug Competition Enhancement Act

6 filings
S 1041
Affordable Prescriptions for Patients Act

6 filings
S 1096
Preserve Access to Affordable Generics and Biosimilars Act

3 filings

Reported by year 2 years

2026 $130,000 2 filings
2025 $140,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 4
Federal Trade Commission (FTC) 2

Recent filings 6 total

Q2

THE GIBSON GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $70,000 income · posted Jul 10, 2026

View → Q1

THE GIBSON GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 9, 2026

View → Q4

THE GIBSON GROUP, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 16, 2026

View → Q3

THE GIBSON GROUP, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $30,000 income · posted Oct 13, 2025

View → Q2

THE GIBSON GROUP, LLC

2nd Quarter (Apr 1 - June 30) 2025 · House · $30,000 income · posted Jul 21, 2025

View → Q1

THE GIBSON GROUP, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · $30,000 income · posted Apr 8, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.